Cargando…
Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease
BACKGROUND: Hypoglycemia is common in patients with end-stage renal disease (ESRD). We identified the incidence and timing of hypoglycemia and its risk factors in hospitalized patients with ESRD after the treatment of hyperkalemia with insulin. METHODS: We conducted a retrospective study of all hosp...
Autores principales: | Apel, Jill, Reutrakul, Sirimon, Baldwin, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377748/ https://www.ncbi.nlm.nih.gov/pubmed/25852884 http://dx.doi.org/10.1093/ckj/sfu026 |
Ejemplares similares
-
SUN-179 Prolonged Hypoglycemia from Insulin Degludec
por: Kothari, Vallari, et al.
Publicado: (2019) -
The Association of Insulin-dextrose Treatment with Hypoglycemia in Patients with Hyperkalemia
por: Crnobrnja, Ljiljana, et al.
Publicado: (2020) -
Insulin for the treatment of hyperkalemia: a double-edged sword?
por: Li, Tingting, et al.
Publicado: (2014) -
Hyperkalemia and Electrocardiogram Manifestations in End-Stage Renal Disease
por: Rafique, Zubaid, et al.
Publicado: (2022) -
Hypoglycemia following intravenous insulin plus glucose for hyperkalemia in patients with impaired renal function
por: Coca, Armando, et al.
Publicado: (2017)